Michal Sheffer, Ph.D.
Affiliations: | 2012 | Weizmann Institute of Science, Rehovot, Israel |
Area:
Oncology, Molecular BiologyGoogle:
"Michal Sheffer"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Eytan Domany | grad student | 2012 | Weizmann Institute | |
| (Implications of genomic instability in colorectal cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| de Matos Simoes R, Shirasaki R, Downey-Kopyscinski SL, et al. (2023) Genome-scale functional genomics identify genes preferentially essential for multiple myeloma cells compared to other neoplasias. Nature Cancer. 4: 754-773 |
| Sheffer M, Lowry E, Beelen N, et al. (2021) Genome-scale screens identify factors regulating tumor cell responses to natural killer cells. Nature Genetics |
| Dashevsky O, De Matos Simoes R, Shirasaki R, et al. (2020) Use of Olfactory Receptor Genes As Controls for Genome-Scale CRISPR Functional Genomic Studies to Define Treatment Resistance Mechanisms Blood. 136: 36-36 |
| De Matos Simoes R, Shirasaki R, Tang H, et al. (2020) POU2AF1 As a Master Regulator of Oncogenic Transcription Factor Networks in Myeloma Blood. 136: 18-19 |
| Sheffer M, Mitsiades C. (2020) 36 Molecular events regulating solid tumor cell responses to natural killer cells Journal For Immunotherapy of Cancer. 8: A37-A37 |
| De Matos Simoes R, Shirasaki R, Downey-Kopyscinski SL, et al. (2019) Systematic Characterization of Genes Representing Preferential Molecular Vulnerabilities for Myeloma Cells Compared to Other Neoplasias - Implications for the Biology and Therapeutic Targeting of Myeloma Blood. 134: 4407-4407 |
| Gandolfi S, Sheffer M, Dufva O, et al. (2019) Heterogeneity of Molecular Mechanisms Determining Blood Cancer Cell Lines Resistance to Natural Killer Cells in the Context of Tumor-Stromal Interactions: Insights from Studies of Pooled DNA-Barcoded Cell Line Panels Blood. 134: 620-620 |
| Shirasaki R, Gandolfi S, De Matos Simoes R, et al. (2019) Functional Characterization of E3 Ligases and Their Regulators: Therapeutic Implications for Development of New Proteolysis-Targeting Chimeric Degraders of Oncoproteins Blood. 134: 318-318 |
| Dufva O, Saeed K, Gandolfi S, et al. (2019) CRISPR Screens Identify Mechanisms of Natural Killer Cell Evasion across Blood Cancers Blood. 134: 3597-3597 |
| Tang H, Shirasaki R, Simoes RDM, et al. (2019) Functional Characterization of Genes Driving Enhanced Biological Aggressiveness of Myeloma Cells: Identification of Novel and Understudied Drivers of Myeloma Blood. 134: 313-313 |